Leiden, Netherlands · Founded 2010 · Privately Held (backing)
Operator of a biotechnology company intended to provide technologies to expedite drug discovery and development processes. Ncardia is based in Leiden, Netherlands and was founded in 2010. Its last known valuation is $174 million. It has raised $130 million.
Last price · $/share
—
Implied valuation
$174.0M
Total raised
$129.7M
Last round
—
Team — not yet on record
No current team members for Ncardia are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Ncardia with a free account
·The complete investor list: 12 names
·Watch Ncardia: the Monday email on marks, rounds and moves
